Visionix is the global manufacturer and exclusive sales, service and training provider of Optovue OCT, Visionix screening and refraction systems, as well as Briot and Weco lens finishing equipment in North America.
Virtual Vision Health
Virtual Vision Health is dedicated to revolutionizing eye care by providing professionals with advanced tools for diagnosing and managing ocular conditions. Virtual Eye, developed and researched at Bascom Palmer Eye Institute, is a Virtual Reality Eye Care testing device with a wide range of diagnostic tests, including visual field testing, progression analysis, color sensitivity, pupillography, and more. Our untethered Virtual Eye device eliminates the constraints of traditional SAP equipment, offering unmatched precision, patient comfort, and ease of use for eye care professionals. Virtual Eye is comfortable to wear, allowing for a seamless diagnostic experience. Committed to accessibility, Virtual Vision Health strives to expand access to essential eye care services, offering anytime-anywhere solutions that meet the highest standards of care. Discover the future of eye care with our transformative, patient-friendly solutions at https://virtualvision.health/. | Our mission is to provide eyecare providers with a better way to diagnose and manage ocular conditions. Virtual Eye was developed and developed and researched by Bascom Palmer Eye Institute to conduct visual field testing, glaucoma progression analysis, and more–without the constraints of traditional SAP.
RetinAI
About Ikerian AG and RetinAI Inc. U.S. Established in 2017, Ikerian AG (formerly RetinAI Medical AG) and its subsidiary, RetinAI U.S. Inc. (‘Ikerian’, ‘RetinAI’ and, together, ‘the company’), develops software solutions to accelerate clinical, research and pharmaceutical workflows globally using advanced machine learning and computer vision. Focused on the ophthalmology and optometry market, RetinAI builds tools to collect, organize and analyze health data from the eyes, enabling healthcare professionals to make the right decisions sooner in healthcare. RetinAI’s international team leverages its clinical, technical, and scientific expertise to foster the transition from reactive to preventive medicine for severe eye diseases. A commercial stage company with growing sales from RetinAI Discovery®, RetinAI has established collaborations and partnerships with leading ophthalmology clinical networks and pharmaceutical companies.
Precision Vision
Precision Vision was built on a foundation of excellence, serving clinical trials since the first ETDRS study. Our expertise as the trusted global leader in vision testing tools is the result of decades of dedication and innovation. This commitment to quality extends beyond our products to include dynamic, streamlined certification solutions that deliver higher savings and faster turnarounds for our clients. Brands Include: ETDRS, BCVA, Precision Vision, Pelli-Robson, Mars, Radner, MNRead, IReST, BRVT, Teller, Reichert, Katena, CATS, SpotChecks, Bailey-Lovie, Double-Happy, Blink, Vortex, Barron, Onatec, ASICO, Sharpoint, EagleVision, Sensortek, and more!
OpZira, Inc.
OpZira, Inc. is a forward-thinking ophthalmic medical device company founded on a legacy of research excellence. The company delivers innovative technologies designed to enhance the detection and monitoring of ocular disease. OpZira’s creation follows Alcon’s acquisition of LumiThera and its Valeda® Light Delivery System, the first and only FDA-authorized treatment for dry AMD. AdaptDx Pro® measures dark adaptation speed. Impaired dark adaptation speed is a key early indicator of rod-mediated dysfunction, one of the first functional signs of retinal dysfuction AdaptDx Pro is available in the U.S. NOVA™ Vision Testing System is an electrophysiology platform that provides objective assessments of the visual and neuro-visual pathway. VEP is available in the U.S. and select international markets. ERG is available outside of the U.S. For more information, visit https://opzira.com. AdaptDx Pro and NOVA are available through AdaptDx, Inc. and Diopsys, Inc., respectively.
OCULUS, Inc.
OCULUS has been setting milestones in the eye care industry since 1895. Our range of products includes the Pentacam®, perimeters, topographers, pachymeters, autorefractors, keratometers, etc. Then in the early ‘80s, OCULUS Surgical developed the world’s first non-contact wide-angle viewing system for vitreoretinal surgery: the SDI®/BIOM®. Visit our booth #2626.
Metrovision
Metrovision is specialized in multimodal medical devices for testing visual functions for over 30years. Our devices include tests not only for standard clinical use, but also for advanced clinical research, to evaluate the gene therapies efficacy etc. We have already equipped major reference centers in the United States and Europe. Metrovision is world leader in: • Vision psychophysics: visual field (automatic and Goldmann), dark adaptation, FST (Full Field Threshold), PAT (Photo Aversion Threshold) • Vision electrophysiology: Standard ERG & PEV, Multifocal ERG & VEP, Sweep VEP, EOG • Study of eye movements with reading tests, video oculography (saccades, pursuits etc.), pupillometry, fixation monitoring
machineMD
machineMD innovates at the intersection of ophthalmology and neuroscience. Their first medical device, neos®, signals a new era in oculometrics with standardized, objective, and quantitative functional eye exams. Read about the latest advances in ocular motor and pupil biomarkers for neurological disorders: https://doi.org/10.1093/braincomms/fcag102